Cancer BiologybioRxivPreprint
AXL-TBK1 driven nuclear AKT3 promotes metastasis
E. N. Arner, J. M. Westcott, S. Hinz…·R. A. Brekken
This study identifies AXL-TBK1-driven nuclear AKT3 as a driver of EMT and metastasis, showing that selective AKT3 inhibition reduces tumor progression in breast cancer.
DOI 10.1101/2022.01.17.476632